Diabetes and hypertension: a comprehensive report on management and the prevention of cardiovascular and renal complications.
作者信息
Handelsman Yehuda
机构信息
Metabolic Institute of America, Tarzana, CA 91356, USA.
出版信息
J Clin Hypertens (Greenwich). 2011 Apr;13(4):221-3. doi: 10.1111/j.1751-7176.2011.00453.x.
Abstract
摘要
相似文献
1
Diabetes and hypertension: a comprehensive report on management and the prevention of cardiovascular and renal complications.
J Clin Hypertens (Greenwich). 2011 Apr;13(4):221-3. doi: 10.1111/j.1751-7176.2011.00453.x.
2
Hypertension and the kidney.
Semin Nephrol. 2005 Jul;25(4):236-45. doi: 10.1016/j.semnephrol.2005.02.008.
3
What to treat? The structural basis for renal and vascular complications and hypertension, and the role of angiotensin converting enzyme inhibition. Symposium, 26th meeting of the European Association for the Study of Diabetes. Dublin, Ireland, 10 September 1991.
J Hypertens Suppl. 1992 Apr;10(1):S1-53.
4
Cardiovascular and renal disease in untreated and treated hypertension.
Contrib Nephrol. 1994;109:65-9. doi: 10.1159/000423289.
5
Editorial: Cardiovascular and renal 2020: Cardiovascular protection by antidiabetic drugs: Key mechanisms and current clinical data.
Curr Opin Pharmacol. 2020 Oct;54:vii-ix. doi: 10.1016/j.coph.2020.12.003.
6
[Nephrology and hypertension].
Journ Annu Diabetol Hotel Dieu. 2003:261-77.
7
[What is a good marker for better antihypertensive therapy in diabetic patients when coexisting with hypertension].
Nihon Rinsho. 2002 Sep;60 Suppl 9:679-84.
8
Preventing cardiovascular and renal complications in the management of hypertension and metabolic syndrome.
Expert Opin Pharmacother. 2007 Sep;8(13):2001-9. doi: 10.1517/14656566.8.13.2001.
9
When hypertension and diabetes coexist: strategies for cardiorenal protection.
Postgrad Med. 2000 Oct;108(5 Suppl):12-8. doi: 10.3810/pgm.10.2000.suppl8.46.
10
Evidence-based treatment of hypertension in patients with type 2 diabetes.
Acta Clin Belg. 2001 Mar-Apr;56(2):96-102. doi: 10.1179/acb.2001.017.
引用本文的文献
1
The Association Between Triglyceride Glucose-Body Mass Index and Kidney Impairment in Patients with Type 2 Diabetes Mellitus.
Diabetes Metab Syndr Obes. 2024 Sep 16;17:3447-3453. doi: 10.2147/DMSO.S477836. eCollection 2024.
本文引用的文献
1
Standards of medical care in diabetes--2011.
Diabetes Care. 2011 Jan;34 Suppl 1(Suppl 1):S11-61. doi: 10.2337/dc11-S011.
2
Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial.
Diabetes Care. 2011 Jan;34(1):34-8. doi: 10.2337/dc10-1420. Epub 2010 Nov 8.
3
Effects of the Dietary Approaches to Stop Hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients: a randomized crossover clinical trial.
Diabetes Care. 2011 Jan;34(1):55-7. doi: 10.2337/dc10-0676. Epub 2010 Sep 15.
4
Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.
JAMA. 2010 Jul 7;304(1):61-8. doi: 10.1001/jama.2010.884.
5
Effect of valsartan on the incidence of diabetes and cardiovascular events.
N Engl J Med. 2010 Apr 22;362(16):1477-90. doi: 10.1056/NEJMoa1001121. Epub 2010 Mar 14.
6
Effects of intensive blood-pressure control in type 2 diabetes mellitus.
N Engl J Med. 2010 Apr 29;362(17):1575-85. doi: 10.1056/NEJMoa1001286. Epub 2010 Mar 14.
7
Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006.
Am J Med. 2009 May;122(5):443-53. doi: 10.1016/j.amjmed.2008.09.047.
8
Blood pressure control, risk factors and cardiovascular prognosis in patients with diabetes: 30 years of progress.
J Hypertens Suppl. 2008 Sep;26(3):S7-13.
9
Effect of a multifactorial intervention on mortality in type 2 diabetes.
N Engl J Med. 2008 Feb 7;358(6):580-91. doi: 10.1056/NEJMoa0706245.
10
Diabetes and hypertension: epidemiology of the relationship and pathophysiology of factors associated with these comorbid conditions.
J Cardiometab Syndr. 2007 Spring;2(2):124-30. doi: 10.1111/j.1559-4564.2007.06368.x.
Zotero 插件